Disease management

Also, a project developing an AI-powered application for preventing cognitive decline among seniors has won a $2 million grant from the New Zealand government.

Users of XRHealth's immersive therapeutic platform will be able to receive real-time movement analysis feedback during rehabilitation.

The company will utilize the funds to accelerate the development of its clinical diagnostic platform and expand its partnerships with pharmaceutical and biotechnology firms.

The company will use the funds to move into the female health space and increase screening and preventive care.

The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.

Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization.

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

Technological innovation has the power and promise to transform healthcare. This series spotlights companies developing such cutting-edge innovations—ranging from brain-computer and muscle-machine interfaces to 3D-printed breast bioprostheses and beyond.

The wristband is designed to alleviate essential tremors by modulating the nervous system and restoring motor control.

Also, new mobile applications promoting mental wellbeing have been launched.